Canada’s Drug Agency is pleased to announce the recipients of our 2024 Recognition Awards. These awards honour individuals who are pushing the science of health technology assessment (HTA) forward, mentoring the next generation of leaders, and helping to grow Canada’s reputation for excellence in the field.
This year marks the introduction of a new award that recognizes early-career professionals with the potential to become leaders in health economics. The award is named in honour of the late Dr. Murray Krahn, a beloved physician and giant in the field of economic evaluation and HTA.
Dr. Mina Tadrous is at the forefront of research that has led to meaningful change at both the policy and patient level. At the Ontario Drug Policy Research Network (ODPRN), he played a key role in implementing a novel framework for drug class reviews that enhanced standard HTA methods with patient and citizen perspectives and real-world evidence (RWE). This approach is driving formulary modernization in Ontario and elsewhere.
More News
Image
PharmD student receives Volunteer Award from Life Sciences Ontario
Simonne Rauch is recognized for her contributions to ambassador and mentorship programs.
Read More
Image
Celebrating Excellence: Mike Folinas Receives 2024-25 Exemplary U of T Ambassador Award
Mike Folinas has received the 2024–25 Exemplary U of T Ambassador Award for his outstanding service and leadership in supporting the academic community.
Read More
Image
Structural biology research takes aim at rare neurodegenerative disease
Rachel Harding leads research to understand protein responsible for Huntington’s disease and advance drug discovery
Read More